A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL
Clinical trial NCT04438044 · UNKNOWN
Trial details
- NCT number
- NCT04438044
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-18
- Primary completion
- 2023-12-31
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.